Medical Marijuana Research Act of 2017

Summary

Medical Marijuana Research Act of 2017 This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research with marijuana for medical purposes. The Drug Enforcement Administration must register: (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research. The Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 25 July 2017

   Introduced

   Introduced in House

   Source: IntroReferral

2. 25 July 2017

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

3. 25 July 2017

   Introduced

   Introduced in House

   Source: IntroReferral

4. 28 July 2017

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 6 September 2017

   Referred

   Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 25 July 2017 · Download file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 25 July 2017

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 25 July 2017

  ViewDownloadOpen at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

• Introduced in House

  summary · EN · 25 July 2017

  Open at official source

  Leesvertaling

  Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

  Vertaal naarNL · DutchDE · GermanFR · FrenchES · SpanishIT · ItalianPL · PolishPT · PortugueseSV · SwedishDA · DanishFI · FinnishEL · GreekCS · CzechHU · HungarianRO · RomanianBG · BulgarianHR · CroatianSK · SlovakSL · SlovenianLT · LithuanianLV · LatvianET · EstonianGA · IrishMT · Maltese

  Vertaal document

  Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

• Rep. Harris, Andy [R-MD-1] · R · Sponsor
• Rep. Blumenauer, Earl [D-OR-3] · D · Sponsor
• Rep. Griffith, H. Morgan [R-VA-9] · R · Sponsor
• Rep. Lofgren, Zoe [D-CA-18] · D · Sponsor
• Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
• Carlos Curbelo · R · Cosponsor
• Rep. Amodei, Mark E. [R-NV-2] · R · Cosponsor
• Rep. Roe, David P. [R-TN-1] · R · Cosponsor
• Rep. Guthrie, Brett [R-KY-2] · R · Cosponsor
• · hsju00 · Standing
• · hsif00 · Standing

Related records

• related to → Responsibly Addressing the Marijuana Policy Gap Act of 2017
• related to → Responsibly Addressing the Marijuana Policy Gap Act of 2017